FY2024 EPS Estimates for Addus HomeCare Boosted by Analyst

Addus HomeCare Co. (NASDAQ:ADUS) – Investment analysts at KeyCorp increased their FY2024 earnings per share (EPS) estimates for shares of Addus HomeCare in a research report issued to clients and investors on Monday, January 6th. KeyCorp analyst M. Gillmor now expects that the company will earn $4.52 per share for the year, up from their prior estimate of $4.50. KeyCorp currently has a “Strong-Buy” rating on the stock. The consensus estimate for Addus HomeCare’s current full-year earnings is $4.59 per share. KeyCorp also issued estimates for Addus HomeCare’s Q1 2025 earnings at $1.14 EPS, Q2 2025 earnings at $1.31 EPS, Q3 2025 earnings at $1.34 EPS, Q4 2025 earnings at $1.47 EPS and FY2025 earnings at $5.26 EPS.

A number of other analysts have also weighed in on the stock. Royal Bank of Canada restated an “outperform” rating and set a $136.00 price objective on shares of Addus HomeCare in a research note on Thursday, November 14th. Oppenheimer boosted their price objective on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a report on Monday, September 23rd. Macquarie reiterated an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research note on Monday, November 4th. Citizens Jmp upgraded Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. Finally, JMP Securities initiated coverage on Addus HomeCare in a research report on Monday, December 16th. They set an “outperform” rating and a $150.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, nine have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, Addus HomeCare currently has an average rating of “Buy” and an average target price of $133.67.

Addus HomeCare Price Performance

Shares of NASDAQ:ADUS opened at $126.42 on Thursday. The business has a fifty day moving average price of $125.04 and a 200-day moving average price of $125.95. The company has a market capitalization of $2.29 billion, a PE ratio of 28.93, a PEG ratio of 2.11 and a beta of 1.00. Addus HomeCare has a 1-year low of $85.94 and a 1-year high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The company had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. During the same period last year, the business earned $1.03 EPS. Addus HomeCare’s quarterly revenue was up 7.1% compared to the same quarter last year.

Institutional Trading of Addus HomeCare

Several institutional investors have recently made changes to their positions in ADUS. Wasatch Advisors LP lifted its stake in Addus HomeCare by 11.8% in the 3rd quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company’s stock worth $138,782,000 after purchasing an additional 110,010 shares in the last quarter. Point72 Asset Management L.P. increased its holdings in shares of Addus HomeCare by 73.4% in the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock worth $86,598,000 after purchasing an additional 315,602 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Addus HomeCare by 0.8% in the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock worth $82,930,000 after buying an additional 5,421 shares in the last quarter. State Street Corp boosted its stake in Addus HomeCare by 4.4% during the third quarter. State Street Corp now owns 663,610 shares of the company’s stock valued at $88,280,000 after buying an additional 27,990 shares during the last quarter. Finally, Principal Financial Group Inc. grew its holdings in Addus HomeCare by 17.5% during the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock valued at $67,293,000 after buying an additional 75,409 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Insider Buying and Selling at Addus HomeCare

In related news, EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction on Monday, December 9th. The shares were sold at an average price of $121.00, for a total transaction of $272,250.00. Following the transaction, the executive vice president now owns 10,217 shares in the company, valued at approximately $1,236,257. The trade was a 18.05 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO R Dirk Allison sold 12,500 shares of the stock in a transaction on Monday, November 25th. The stock was sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the sale, the chief executive officer now owns 141,897 shares of the company’s stock, valued at $17,476,034.52. The trade was a 8.10 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 39,750 shares of company stock valued at $4,930,750. Insiders own 4.60% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.